Patient-Centric Care
17/02/2025
NEWS ROOM
21,900
employees
100 million
patients treated each day
worldwide with Servier Group medicines.
20％
of revenue from brand-name
medicines invested in R&D in every year
€5.3 billion euros
in revenue in 2020/2021 comprising €4
billion for brand-name medicines and €1.3 billion for generic medicines
4 therapeutic areas
oncology, cardiometabolism, neuroscience
and immuno-inflammation
Servier Medical Art is a medical image bank that we make available to illustrate your medical releases.
Last publications on our social networks
OUR COMMITMENTS
At Servier, we believe that providing future generations with a healthier world is the very essence of our mission. As a leading pharmaceutical company, we work towards our purpose with passion, dedication, and determination.
First and foremost, our conviction embodies patient-centricity, as well as our code of ethics and compliance, our corporate social responsibility policy, and our endowment fund.
We nurture individual and collective commitment by giving our employees a fulfilling and rewarding work environment conducive to creativity and innovation